This webinar for pharmaceutical industry executives features industry leaders Dr. Hansa Bhargava (Healio/Physician), Anthony Manson (Healio), Simon Smith (Klick), and Michael Sivak (AstraZeneca) as they explore the rapidly evolving role of artificial intelligence (AI) in oncology, with a focus on how oncologists are leveraging AI platforms to search, access and synthesize medical literature, clinical news and information at the point of care.

Key discussion points include:

• Real-Time Literature and Guideline Integration: AI platforms integrate the latest clinical research, national guidelines, and institution-specific protocols, providing oncologists with up-to-date, evidence-based recommendations during patient visits. This reduces the time spent searching for and reviewing literature, enhancing decision-making efficiency.
• Enhanced Search and Decision Support: AI tools can rapidly scan vast databases of medical journals and research, identifying relevant studies, biomarkers, and treatment options tailored to individual patients. This enables more precise and personalized care, especially as new therapies and diagnostics emerge.
• Continuous Learning: These platforms are designed to learn and update dynamically, incorporating new research findings and guideline changes to ensure oncologists always work with the most current evidence.

This session offers insights into how pharmaceutical leaders can align their strategies with these technological advancements, anticipate future needs, and support the integration of AI-driven tools in oncology practices.